Association between tumor necrosis factor inhibitor therapy and reduced risk of major adverse cardiovascular events in patients with psoriasis - 21/04/16
Jashin Wu, MD, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, United States; Michael Batech, PhD, SCPMG, Department of Research and Evaluation, Pasadena, CA, United States; Shivani Reddy, University of Illinois at Chicago College of Medicine, Chicago, IL, United States; Nehal Mehta, MD, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, United States
Le texte complet de cet article est disponible en PDF. Supported 100% by AbbVie. AbbVie did not participate in the design, study conduct, interpretation of data, review, and or approval of the abstract. |
Vol 74 - N° 5S1
P. AB237 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?